Abstract:Background: Cardiovascular diseases (CVD) are the leading cause of death in the United States. Statins, a class of hydroxy-methylglutaryl-coenzyme A reductase (HMGCR) inhibitors, have been proven to be effectively prevent and treat CVD by improving vascular functions independent of their cholesterol-lowering effect. However, the molecular mechanisms by which statins improve cardiovascular functions remain elusive. In this study, we used human induced pluripotent stem cells-derived endothelial cells (hiPSC-ECs) to explore the protective role of statins in the vascular system. Methods and Results: hiPSCs were generated from 3 healthy individuals and differentiated into endothelial cells using two different iPSC clones and two batches (4 biological replicates for each individual). hiPSC-ECs of each individual were treated with simvastatin or a vehicle control. The RNA-sequencing analysis was performed on 12 control and 12 statin-treated hiPSC-ECs. A total number of 2,580 differentially expressed genes (DEGs) were found in simvastatin-treated hiPSC-ECs. Gene enrichment analysis revealed that statin-upregulated DEGs were highly enriched in angiogenesis and anti-inflammation pathways. Interestingly, statin-downregulated DEGs were significantly enriched in epigenetic regulation and nucleosome assembly pathways, suggesting an epigenetic regulatory role of stains in vascular gene expression. To test this hypothesis, we further performed the Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) analysis on vehicle or simvastatin treated hiPSC-ECs. Transcription factor (TF) binding motif analyses of ATAC-seq peaks using HOMER revealed that YAP/TEAD binding was the most significantly downregulated TF after statin treatment. Furthermore, we observed that statin can improve endothelial functions (e.g., angiogenesis and nitric oxide production) after the YAP activity was inhibited. The ChIP-seq analysis showed that statin downregulated the expression levels of genes associated with the endothelial-to-mesenchymal transition (EndoMT) by attenuating the binding capacity of YAP. As such, simvastatin effectively rescued diabetic vascular dysfunction mainly through inhibiting EndoMT. Conclusion: We found that statins can improve endothelial functions through attenuating the chromatin accessibility of EndoMT-related genes, a process tightly regulated by the activity of YAP. These findings will provide novel insights into the protective mechanisms of statins in the cardiovascular system beyond their cholesterol-lowering effects.

Overview of Therapeutic Effects of Statins on Inflammatory Diseases Through Regulating Adhesive Molecules

Overview of therapeutic effects of stains on inflammatory diseases through regulating adhesive molecules.

Anti-inflammatory Properties of Statins

Abstract 325: The Regulation of Endothelial Function Through Hmgcr/mevalonate Pathway Mediated Yap Activity

Dual Effects of Statins Therapy in Systemic Lupus Erythematosus and SLE-related Atherosclerosis: the Potential Role for Regulatory T Cells

Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities

The Effects of Statins on Cell Adhesion Molecules in Dyslipidemic Patients

Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

Statins Induce the Accumulation of Regulatory T Cells in Atherosclerotic Plaque

Effects of statins on proliferation,migration and apoptosis of vascular smooth muscle cells and its mechanism

Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels

To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer

Atheroprotective Effects of Statins in Patients with Unstable Angina by Regulating the Blood-Borne Microrna Network

Effects of different applications of statins on ICAM-1,VCAM-1 and MCP-1 in patients with coronary heart diseases

Effects of Statins on the Proliferation and Migration of Vascular Smooth Muscle Cells by Regulation of Fibrinolysis

Simvastatin Attenuates the Additive Effects of TNF-α and IL-18 on the Connexin 43 Up-Regulation and Over-Proliferation of Cultured Aortic Smooth Muscle Cells.

Effect of Statins on Platelet Activation and Function: From Molecular Pathways to Clinical Effects

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis

Targeting AMPK by Statins: A Potential Therapeutic Approach

Pleiotropic effects of statins: new therapeutic targets in drug design

Simvastatin Inhibits Inflammatory Response in Lipopolysaccharide (Lps)-Stimulated RAW264.7 Macrophages Through the Microrna-22/Cyr61 Axis.